The cost of immunotherapy in Spain typically ranges from $12,000 to $25,000. Prices vary depending on the type of immunotherapy used (such as monoclonal antibodies, checkpoint inhibitors, or CAR-T cell therapy), the number of treatment cycles, the clinic, and the treating physician’s expertise. In the United States, the average price is $30,000 (according to the American Cancer Society). This means immunotherapy in Spain can be about 38% less than in the U.S.
Spanish clinics usually include initial consultation, diagnostic tests, medication administration, monitoring during treatment, and scheduled follow-up visits in the overall cost. In the U.S., the listed price often covers only the medication, with separate charges for doctor’s visits, lab tests, and infusion services. Always confirm exactly what’s included at each clinic.
Why choose Spain for immunotherapy?
Access advanced Immunotherapy solutions in trusted clinics .
| Turkey | Austria | Spain | |
| Immunotherapy | from $2,200 | from $30,000 | from $12,000 |
| Sarcoma Immunotherapy | from $18,000 | from $60,000 | from $80,000 |
| Immunotherapy for prostate cancer | from $12,000 | from $30,000 | from $35,000 |
| Immunotherapy for lung cancer | from $18,000 | from $30,000 | from $30,000 |
| Immunotherapy for breast cancer | from $9,500 | from $35,000 | from $45,000 |
Medically reviewed by
Fahad MawloodNo hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy journey.
Dr. Graupera heads the Hematology Oncology Department at Sant Joan De Déu – one of Europe's top children's hospitals. His research focuses on pediatric cancer treatments.
Dr. Graus defined the first strict diagnostic criteria for paraneoplastic neurological syndromes – a key breakthrough in immunotherapy-related neurotoxicity.
Leader in immunotherapy research for melanoma and breast cancer – Dr. Soberino has contributed to groundbreaking drug approvals that revolutionized treatment.
World-renowned leader in Chronic Lymphocytic Leukemia (CLL) – Professor Bosch leads over 80 clinical trials on new treatments.
Written by Kateryna Zamkovska
Written by Kateryna Zamkovska
Written by Kateryna Zamkovska
When considering Immunotherapy, it’s important to understand the different techniques and which is best suited for you. Here’s a concise comparison of popular options:
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.
CAR T-cell therapy is a personalized immune system therapy that modifies a patient's T-cells to target and destroy cancer cells.